McMaster researcher John Eikelboom co-leads the pan-African REVIVE trial, which will test a low-cost antibiotic as an effective tool to address the HIV crisis in Africa.
The findings from researchers at McMaster and the University of Maryland could lead many hospitals to consider a policy change regarding what they use before fracture surgeries.
Anthony Levinson, from Psychiatry & Behavioural Neurosciences talks about the disease's effects and symptoms, as well as changes to watch for.
McMaster logo
McMaster logo
